New Division Created At PhRMA
The Pharmaceutical Research and Manufacturers of America has created anew division to expand and improve its policy-making and strategic planning capacity.
Director of health policy Steven Cole has been promoted to head the new division, becoming vice president for policy. He will report directly to executive vice president for policy and strategic affairs, Judy Bello, and work closely with Gary Persinger's research and information services division in an integrated team approach to research-based policy analysis, a PhRMA spokesman told the Marketletter.
The PhRMA says the reorganization will allow the research and policy team to develop a coordinated approach to any legislative proposals, allowing for international, federal and state implications.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze